Prem S. Shah - Feb 21, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Co-President of Retail
Signature
/s/ Prem S. Shah
Stock symbol
CVS
Transactions as of
Feb 21, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 03:33 PM
Previous filing
Jan 10, 2022
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Award $0 +47.6K +397.65% $0.00 59.6K Feb 21, 2022 Direct F1
holding CVS Common Stock (PSUs) 41.5K Feb 21, 2022 Direct
holding CVS Common Stock (restricted) 575 Feb 21, 2022 Direct F2
holding CVS Common Stock (restricted) 2.88K Feb 21, 2022 Direct F3
holding CVS Common Stock (restricted) 15.4K Feb 21, 2022 Direct F4
holding CVS Common Stock (restricted) 1.81K Feb 21, 2022 Direct F5
holding CVS Common Stock (restricted) 1.93K Feb 21, 2022 Direct F6
holding CVS Common Stock (restricted) 6.39K Feb 21, 2022 Direct F7
holding CVS Common Stock (restricted) 4.37K Feb 21, 2022 Direct F8
holding CVS Common Stock (restricted) 2.8K Feb 21, 2022 Direct F9
holding CVS Stock Unit (deferred) 5.63K Feb 21, 2022 Direct F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 5.87K Feb 21, 2022 Common Stock 5.87K $104.82 Direct F11
holding CVS Stock Option 5.35K Feb 21, 2022 Common Stock 5.35K $102.26 Direct F12
holding CVS Stock Option 1.69K Feb 21, 2022 Common Stock 1.69K $62.20 Direct F13
holding CVS Stock Option 12.6K Feb 21, 2022 Common Stock 12.6K $54.19 Direct F14
holding CVS Stock Option 34.3K Feb 21, 2022 Common Stock 34.3K $58.34 Direct F15
holding CVS Stock Option 32.8K Feb 21, 2022 Common Stock 32.8K $74.30 Direct F16
holding CVS Stock Option 26.6K Feb 21, 2022 Common Stock 26.6K $75.24 Direct F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
F2 Consists of remaining Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan (ICP). Restrictions lapse on 02/28/2022.
F3 Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in two equal installments commencing on 04/01/2022.
F4 Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in three equal installments commencing on 04/01/2022.
F5 Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions lapse on 04/01/2022.
F6 Consists of remaining RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 ICP. Restrictions lapse in two equal installments commencing on 02/28/2022.
F7 Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in four equal installments commencing on 04/01/2022.
F8 Consists of Matching RSUs awarded pursuant to Issuer's Partnership Equity Program, a sub-plan under its ICP, and dividend equivalents on the Matching RSUs. Restrictions lapse on the RSUs on 08/31/2023.
F9 Consists of RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan under its 2017 ICP. Restrictions lapse in three equal installments commencing on 02/26/2022.
F10 Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
F11 Option becomes exercisable in four equal installments commencing 04/01/2017.
F12 Option becomes exercisable in four equal installments commencing 04/01/2016.
F13 Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
F14 Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised.
F15 Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
F16 Option becomes exercisable in three equal installments commencing 04/01/2022.
F17 Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023.